Question

In: Computer Science

Q1b.Briefly explain the following properties if flowcharts. i. Input/output ii. Finiteness iii. Definiteness iv. Efficiency v....

Q1b.Briefly explain the following properties if flowcharts. i. Input/output ii. Finiteness iii. Definiteness iv. Efficiency v. Generality 5 Marks

Q1c. Briefly outline the purpose five symbols used in flowcharts designing with respect to software design and modelling. 5 Marks

Solutions

Expert Solution

Input / Output : Every flowchart takes some input and processes the input and produce the Output.
Finiteness : Every process must contain finite number of steps.
Every problem can be solved in finite steps.
Definiteness: The steps must be specified without ambiguity(clear and precise)
Efficiency : The operations must be efficient to be carried Out.
Generality : The algorithm must produce correct result for various input set.

1.c.

parallelogram : Symbol used to specify input and Output
Rectangle : symbol to specify various arithmetic operations like computing addition,
subtraction , multiplication etc.
Rhombus or Diamond:This symbol is used to specify the conditon to take decision
Round end rectangle :To specify start and stop symbol.
Rectangle with double lines :To specify declaration of variables.

circle:To connect various parts of flowchart.

Arrow : to specify the flow of control of execution.


Related Solutions

​(i) product constituents, (ii) branding, (iii) packaging, (iv) product appearance, and (v) product quality
Give one example each , as to how(i) product constituents, (ii) branding, (iii) packaging, (iv) product appearance, and (v) product quality are adopted in global marketing efforts in an effort to meet the demands of any of the many stakeholders such as customer, government, and others. - list in bullet points format - List one point each for the five items listed above.
Explain the following in relation to antiretroviral therapy: i. Pharmacodynamics ii. Pharmacokinetics iii. Pharmacogenomics iv. Drug...
Explain the following in relation to antiretroviral therapy: i. Pharmacodynamics ii. Pharmacokinetics iii. Pharmacogenomics iv. Drug availability during contraception use and pregnancy v. Drug-drug interactions during treatment
explain the following Neurotransmitters: i. Serotonin ii. Histamine iii. Dopamine ( 5 marks each ) iv....
explain the following Neurotransmitters: i. Serotonin ii. Histamine iii. Dopamine ( 5 marks each ) iv. Glycine v. Glutamate vi. Gama amino butyric acid (GABA) vii. Nitric oxide (NO)
2014 I 31 2017 I 69 II 24 II 54 III 23 III 46 IV 16...
2014 I 31 2017 I 69 II 24 II 54 III 23 III 46 IV 16 IV 32 2015 I 42 2018 I 82 II 35 II 66 III 30 III 51 IV 23 IV 38 2016 I 53 2019 I 91 II 45 II 72 III 39 III 59 IV 27 IV 41 Create a multiple regression equation incorporating both a trend (t=0 in 2013: IV) and dummy variables for the quarters. Let the first quarter represent the reference...
2014 I 31 2017 I 69 II 24 II 54 III 23 III 46 IV 16...
2014 I 31 2017 I 69 II 24 II 54 III 23 III 46 IV 16 IV 32 2015 I 42 2018 I 82 II 35 II 66 III 30 III 51 IV 23 IV 38 2016 I 53 2019 I 91 II 45 II 72 III 39 III 59 IV 27 IV 41 Create a multiple regression equation incorporating both a trend (t=0 in 2013: IV) and dummy variables for the quarters. Let the first quarter represent the reference...
Explain about the following (i) Ordinary shares (ii) Preference shares (iii) Cost of capital (iv) Weighted...
Explain about the following (i) Ordinary shares (ii) Preference shares (iii) Cost of capital (iv) Weighted average cost of capital (WACC)
Explain the following briefly: i) Potential ordinary share ii) Ordinary share iii) Financial instrument iv) Equity...
Explain the following briefly: i) Potential ordinary share ii) Ordinary share iii) Financial instrument iv) Equity instrument v) Options, warrant and their equivalents State the double entry for the following: i) Pre-acquisition dividend ii) Post-acquisition dividend iii) Impairment in associate iv) Provision for unrealized profit v) Depreciation of plant
8. Use the following table to answer questions I, ii, iii and iv A B C...
8. Use the following table to answer questions I, ii, iii and iv A B C Initial cost $15,000 $9,000 $12,000 Annual benefit $8,000 $2,000 $1,800 Salvage value $5,000 $9,000 0 Life in years 2 years 3 Years Infinity MARR 10% i. The NPW of alt. A is __________________. A) $13,420 B) $17,380 C) $11,000 D) $6,00 ii. The NPW of alt. B is __________________. A) $13,420 B) $17,380 C) $11,000 D) $6,000 iii. The NPW of alt. C is...
1. The general formula of alkanes is: (i) CnH2n+2 (ii) CnH2n-2 (iii) CnH2n (iv) CnH2n+4 (v)...
1. The general formula of alkanes is: (i) CnH2n+2 (ii) CnH2n-2 (iii) CnH2n (iv) CnH2n+4 (v) Cn+2H2n 2. The name of the following compound is: a. Tetrabenzene b. Chrysene c. Coronene d. Anthracene e. Pyrene 3. To achieve noble gas configuration, hydrogen requires………………..whereas chlorine requires…………………in outermost shell. a. Octet, duet b. Singlet, duet c. Duet, octet d. Octet, singlet e. None of the above 4. The ……………. the number of relatively stable resonance contributors, the …………… the resonance energy. a....
Describe the insertion of type I, II, III and IV into the ER membrane? Differences?
Describe the insertion of type I, II, III and IV into the ER membrane? Differences?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT